103 results First application of Towercast in Belgium and merger filing exemption for certain hospital merger The Belgian Competition Authority has applied the Towercast case law in a first case in Belgium. It could possibly try do so again for certain hospital mergers that the legislator has recently exempted from merger filing in Belgium. The Commission’s ‘killer’ pharma campaign: reason to complain? The European Commission is on the prowl in the pharma sector. Recent cases on alleged disparagement and pipeline drugs-killings show that it is not afraid to show its teeth and, ultimately, bite. Shaping the Future: The Belgian Competition Authority’s 2025 Roadmap On 29 April 2025, the Belgian Competition Authority announced its sectoral and strategic priorities. These priorities reflect a confident authority that seeks to strengthen its enforcement tools to meet new challenges in competition law. Belgian Competition Authority confirms jurisdiction for M&A transactions in hospital sector On 14 July 2023, the Belgian Competition Authority confirmed its jurisdiction to review M&A transactions between hospitals, regardless of whether these hospitals belong to the same hospital network. Digital antitrust conduct: too elusive to catch? The ink on the Digital Market Act has barely dried, but fast-evolving digital developments already have competition authorities calling for new tools. Is Big Tech not kept in check by the DMA, the antitrust rules and the EU Merger Regulation after all? Planologische compensatie: een gamechanger in de strijd voor open ruimte? De planologische compensatieplicht is nu wettelijk verplicht bij elke wijziging van een 'zachte' naar een 'harde' bestemming. Wat betekent dit voor toekomstige RUP’s? Ontdek de regels, uitzonderingen én de nieuwe handleiding van het Departement Omgeving. Selectie van recente EU-BE juridische ontwikkelingen in consumentenbescherming Hier vindt u een selectie van recente Belgische en Europese juridische ontwikkelingen in consumentenbescherming. Sélection des récents développements juridiques UE-BE en matière de protection des consommateurs Veuillez trouver ici une sélection des récents développements juridiques belges et européens en matière de protection des consommateurs. Stibbe assists PanTera with the development of its Actinium Production Center Stibbe assisted PanTera in relation to the development of its Actinium Production Center, a pioneering facility dedicated to the large-scale production of Actinium-225 (Ac-225), a vital isotope used in targeted alpha therapy for cancer treatment. The era of FDI screenings kicks off in Belgium The Belgian screening mechanism for FDIs will enter into force on 1 July 2023. The mechanism is designed to safeguard Belgium's critical infrastructure and to protect sectors crucial to Belgium's public order, national security and strategic interests. Greenwashing in the EU financial markets: sustainable finance status update The European financial markets feature numerous financial products with characteristics such as ‘green’, ‘ESG’, ‘sustainable’, ‘climate’, ‘transition’, ‘impact’ or similar. But when is it fair to name or label financial products as such? PFAS in Walloon and Brussels law Per- and polyfluoroalkyl substances (PFAS), known as “forever chemicals” due to their persistence in the environment and very low degradability, have been the subject of several major scandals in Europe in recent years. Les PFAS dans le droit wallon et bruxellois Les substances per- et polyfluoroalkylées (PFAS), surnommées "polluants éternels" en raison de leur persistance dans l’environnement et leur très faible dégradabilité, ont fait l'objet de plusieurs scandales majeurs en Europe ces dernières années. Pagination Previous page Page 3 Page 4 Page 5 Current page 6
First application of Towercast in Belgium and merger filing exemption for certain hospital merger The Belgian Competition Authority has applied the Towercast case law in a first case in Belgium. It could possibly try do so again for certain hospital mergers that the legislator has recently exempted from merger filing in Belgium.
The Commission’s ‘killer’ pharma campaign: reason to complain? The European Commission is on the prowl in the pharma sector. Recent cases on alleged disparagement and pipeline drugs-killings show that it is not afraid to show its teeth and, ultimately, bite.
Shaping the Future: The Belgian Competition Authority’s 2025 Roadmap On 29 April 2025, the Belgian Competition Authority announced its sectoral and strategic priorities. These priorities reflect a confident authority that seeks to strengthen its enforcement tools to meet new challenges in competition law.
Belgian Competition Authority confirms jurisdiction for M&A transactions in hospital sector On 14 July 2023, the Belgian Competition Authority confirmed its jurisdiction to review M&A transactions between hospitals, regardless of whether these hospitals belong to the same hospital network.
Digital antitrust conduct: too elusive to catch? The ink on the Digital Market Act has barely dried, but fast-evolving digital developments already have competition authorities calling for new tools. Is Big Tech not kept in check by the DMA, the antitrust rules and the EU Merger Regulation after all?
Planologische compensatie: een gamechanger in de strijd voor open ruimte? De planologische compensatieplicht is nu wettelijk verplicht bij elke wijziging van een 'zachte' naar een 'harde' bestemming. Wat betekent dit voor toekomstige RUP’s? Ontdek de regels, uitzonderingen én de nieuwe handleiding van het Departement Omgeving.
Selectie van recente EU-BE juridische ontwikkelingen in consumentenbescherming Hier vindt u een selectie van recente Belgische en Europese juridische ontwikkelingen in consumentenbescherming.
Sélection des récents développements juridiques UE-BE en matière de protection des consommateurs Veuillez trouver ici une sélection des récents développements juridiques belges et européens en matière de protection des consommateurs.
Stibbe assists PanTera with the development of its Actinium Production Center Stibbe assisted PanTera in relation to the development of its Actinium Production Center, a pioneering facility dedicated to the large-scale production of Actinium-225 (Ac-225), a vital isotope used in targeted alpha therapy for cancer treatment.
The era of FDI screenings kicks off in Belgium The Belgian screening mechanism for FDIs will enter into force on 1 July 2023. The mechanism is designed to safeguard Belgium's critical infrastructure and to protect sectors crucial to Belgium's public order, national security and strategic interests.
Greenwashing in the EU financial markets: sustainable finance status update The European financial markets feature numerous financial products with characteristics such as ‘green’, ‘ESG’, ‘sustainable’, ‘climate’, ‘transition’, ‘impact’ or similar. But when is it fair to name or label financial products as such?
PFAS in Walloon and Brussels law Per- and polyfluoroalkyl substances (PFAS), known as “forever chemicals” due to their persistence in the environment and very low degradability, have been the subject of several major scandals in Europe in recent years.
Les PFAS dans le droit wallon et bruxellois Les substances per- et polyfluoroalkylées (PFAS), surnommées "polluants éternels" en raison de leur persistance dans l’environnement et leur très faible dégradabilité, ont fait l'objet de plusieurs scandales majeurs en Europe ces dernières années.